Trial Profile
Phase III trial of peramivir in patients with high-risk influenza
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Apr 2010
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza A virus infections; Influenza B virus infections; Influenza virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Shionogi
- 09 Mar 2010 Results presented at 14th International Congress on Infectious Diseases.
- 04 Nov 2009 According to a Shionogi media release, a New Drug Application has been filed based on the results of this and another trial (see profile 700035861).
- 21 Jul 2009 New trial record.